Post-mortem studies suggested a disturbance of the GABAergic system in schizophrenia. Neonatal ventral hippocampal-lesioned (NVHL) rats were used as a neurodevelopmental model of schizophrenia. Here, we characterized the GABAergic system, focusing on the GABA-synthesizing enzyme, GAD67, GABAergic interneuron characteristic proteins, and the GABA transporter, gat-1. As the GABAergic system is crucial to brain excitability, the sensitivity to pentylenetetrazol (PTZ) administration, an antagonist of GABA A receptors, was also evaluated in such rats. Male pups were lesioned with ibotenic acid at postnatal day 7. As adults, they were submitted to standard behavioural tests, i.e. prepulse inhibition of the startle reflex and increased locomotion under apomorphine, to assess the effectiveness of the lesions and the PTZ infusion test before immunohistochemistry of the GABAergic neuron markers. We found a widespread perturbation of the enzyme responsible for GABA synthesis, GAD67 and a decrease of specific interneurons, restricted to the hippocampus, entorhinal and prefrontal cortex, but no alteration of gat-1-positive fibres. The usual behavioural properties of the model, such as hyperlocomotion under apomorphine and a deficit in sensorimotor gating were confirmed. NVHL rats showed changes in cortical excitability reflected by higher susceptibility than sham-operated rats to spike wave discharges and decreased susceptibility to clonic seizures, induced by increasing the dose of PTZ. These findings indicate that a neonatal lesion of the ventral hippocampus elicits alterations in the GABAergic system leading to functional consequences on brain excitability, lending support to the idea that GABAergic systems could be involved in the pathophysiology of schizophrenia.
Introduction
Schizophrenia is a chronic and frequently devastating neuropsychiatric disorder, affecting about 1 % of the world's general population. This syndrome usually appears by the end of the second decade of life (Andreasen, 1995) . The aetiology of schizophrenia is currently unknown. However, the major hypothesis considers that schizophrenia results from an interaction between genetic susceptibility and environmental risk factors which alter neurodevelopmental processes that occur before the onset of diagnostic features of the illness .
Identifying pathophysiological mechanisms of schizophrenia is a long-term goal of most current research on the disease. While the dopamine and glutamate theories are the two major hypotheses, typical antipsychotics do not always improve positive and negative symptoms (Coyle & Tsai, 2004 ; Lieberman & Koreen, 1993) suggesting that neurotransmission pathways, other than dopamine may be involved. Recently, several studies have shown evidence of a role of the GABAergic system in schizophrenia. Indeed, GABAergic interneurons are a principal focus of dopamine innervation, particularly in the prefrontal cortex and striatum, suggesting that the consequences of an augmentation of dopamine liberation could directly be observed in these neurons. Post-mortem studies showed perturbations of the GABAergic system, mainly a decrease in GAD67 expression (Guidotti et al. 2000 ; Heckers & Konradi, 2002 ; Impagnatiello et al. 1998) . This decrease in cortical inhibition by GABAergic interneurons could mediate the symptoms of schizophrenia, and the cognitive disability of patients (Daskalakis et al. 2007 ; Lewis et al. 2005) . Alterations of components of the GABAergic system have been reported in models of acute psychosis, e.g. those induced by injection of NMDA receptor antagonists (Abekawa et al. 2007 ; Braun et al. 2007 ; Morrow et al. 2007) , and in chronic models, e.g. the isolation rearing model (Harte et al. 2007) , the methylazoxymethanol model (Penschuck et al. 2006) and the amygdala activation model (Berretta et al. 2004) .
Several studies suggest that the neonatal excitotoxic lesion of the ventral hippocampus (NVHL) may serve as a heuristic model of schizophrenia (Lipska, 2004) . Indeed, the neonatal insult of the ventral hippocampus at 7 d (PD 7) after birth in the rat may disrupt the development of widespread cortical and subcortical circuits in which the hippocampus is involved, leading to several symptoms sharing similarities with those of schizophrenia patients. When tested as juveniles (PD 35) , NVHL rats are less sociable than controls. In adolescence and adulthood (oPD 56), emergence of 'schizophrenia-like ' behaviour such as supersensitivity to dopaminergic agents, deficits in sensory motor gating shown by prepulse inhibition of the startle reflex (PPI), social interaction and cognitive deficits are observed in NVHL rats (Lipska & Weinberger, 2000) . Antipsychotic drugs normalize some of these abnormal behaviours (Le Pen & Moreau, 2002 ; Lipska, 2004 ; Sams-Dodd, 1997) . These features suggest the validity of its use as a model for schizophrenia. Dysfunction of the GABAergic system was observed in this model, as in schizophrenia patients. Indeed, attenuated cortical expression of one isoform of glutamate decarboxylase, GAD67 (Lipska & Weinberger, 2000) and regional changes in expression of the GABA A receptor subunits and in GABA A receptor binding were reported (Endo et al. 2007 ) giving arguments in favour of a role of the GABAergic system in the abnormal behaviour observed in this model.
In the present study, we first characterized the validity of the NVHL rat model by controlling the size of the lesion and subjecting the animals to specific behavioural tests (PPI and locomotion under apomorphine). In these rats, we characterized the GABAergic system, focusing our work on GABAergic interneurons that differ according to the presence of calcium-binding proteins, namely parvalbumin (PV), calbindin (CB) and calretinin (CR), on the GABAsynthesizing enzyme, GAD67, and one of the predominant GABAergic transporters in mammalian brain, gat-1, localized in neuronal terminals and surrounding astrocytes (Pow et al. 2005 ). Finally, we tested the functional consequences of changes in the GABAergic system, by injecting pentylenetetrazol (PTZ), an antagonist of GABA A receptors. This drug induces different types of seizures depending on the dose tested. The occurrence of seizures directly reflects brain excitability, which in turn is closely linked to GABAergic neurotransmission.
Material and methods

Animals
Female rats with eight male pups provided by Charles River Breeding Centre (L'Arbresle, France) were housed under controlled, uncrowded conditions at 20-22 xC (12-h light/dark cycle, lights on 07 : 00 hours), with food and water ad libitum. All animal experimentation was performed in accordance with the rules of the European Communities Council Directive of November 24, 1986 (86/609/EEC), and the French Department of Agriculture (License no. 67-97). The protocol was agreed by the Ethical Animal Research Committee Board of Louis Pasteur University (CREMEAS no. AL/01/01/01/07). All efforts were made to minimize animal suffering. The experiments were performed on two main groups of animals. The first group of 48 pups underwent surgery (eight sham and 40 NVHL) and the complete analysis, i.e. behavioural testing, PTZ infusion test and immunohistochemistry. In order to ensure that prior PTZ exposure did not affect the GABAergic system we added two reference groups, one of eight sham and one of five NVHL rats that only underwent immunohistochemistry.
Neonatal hippocampal lesion
PD 7 pups weighing 15-25 g were anaesthetized by isoflurane inhalation (5 % for induction and 2-3 % in oxygen for maintenance) and placed in a stereotaxic apparatus over a heating pad (37 xC). A 1 ml Hamilton syringe was lowered into the ventral hippocampus (AP x3.0 mm, ML ¡3.5 mm, DV x5.0 mm from bregma). Ibotenic acid [0.3 ml; 10 mg/ml in artificial cerebrospinal fluid (aCSF), pH 7.4] was delivered bilaterally by a 1 ml Hamilton syringe driven by a microinjection pump (type 5000, David Kopf Instruments, USA) at a rate of 0.12 ml/min to 40 rats. Sham-operated animals (n=8) received 0.3 ml aCSF on each side. Rats were allowed to recover on a heating pad before returning to their home cage with the dam.
Post-hoc verifications of the extension and surface of the lesions
For assessment of lesion size, 40 mm sections were used and stained with Cresyl Violet. Lesion size was calculated with the MCID Elite 7.0 software (Imaging Research Inc., Canada) at four levels of the hippocampus (AP x5.80 mm, x5.30 mm, x4.80 mm, x4.30 mm from bregma) according to the stereotaxic rat brain atlas (Paxinos & Watson, 1986) . Only data from rats with symmetrical bilateral lesions limited to the ventral hippocampus were considered.
Behavioural testing
All rats that were operated on underwent behavioural testing (40 NVHL and eight sham). Only 10 NVHL rats with symmetrical bilateral lesions limited to the ventral hippocampus were included in the final analysis.
PPI
At PD 68-72, rats were placed in a containment box in a sound-attenuating chamber with a background noise of 65 dB. A computer was used to trigger two types of acoustic stimuli, a pure tone (76 dB, duration 25 ms) -which served as the prepulse -and a wideband noise (120 dB, duration 50 ms) -which served as the pulse. The prepulses were amplified and transmitted to loudspeakers placed 10 cm apart on one wall of the cage. The pulses were administered through another loudspeaker placed at the middle top of the cage. The floor was a platform fixed to an electronic scale (Model AL SPCL 3 kg ; SCAIME, France). Its force transducer was connected to an amplifier (SCAIME), which delivered a voltage proportional to the force to an A/D converter (AD800, Analog Devices, France) fitted in the computer. The whole measurement device was calibrated with known weights (to an accuracy of 1 g). The computer recorded the startle reaction for 100 ms after the noise onset (one measure every millisecond). In offline analysis, measurements were discarded if the response did not match the usual delay range for a startle reflex which represents <10 % of cases. In the absence of a startle reaction, the amplitude was designated as 0 and included in the subsequent computations.
Each rat was submitted to a single test session, which started 5 min after placement in the containment box. The initial 10 stimuli consisted of pulses alone, and no recording of the startle was made.
Subsequently, 10 series of 10 measurements were performed, and separated by a random period lasting 10-20 s. For each series, rats were submitted five times to a pulse alone and five times to a prepulse followed by the pulse, in a random sequence. The interval between the end of the prepulse and beginning of the pulse was constant (100 ms).
Calculations of the mean startle amplitudes were made in each condition. The mean startle decreases elicited by the prepulses (expressed as %PPI) were computed for each condition and each rat. The mean %PPI underwent an ANOVA (Statistica Software, USA) with surgical treatment (lesion vs. sham) as the between-group factor.
Locomotion under apomorphine
At PD 100-107, rats were subjected to a locomotion test under apomorphine. Testing was carried out in four plastic cages (base : 30r40 cm ; height 35 cm). They were enclosed in a sound-and light-proof polystyrene box (background noise 65 dB, no light). A passive infrared detector (IRP 124, France) was used to evaluate the movements of the rats. The detector was managed by a computer which recorded the number of times the rat crossed the limits of a beam of the detector for each 5 min period. The measurements started 5 min after a subcutaneous injection of apomorphine (0.35 mg/kg and 0.7 mg/kg), dissolved in saline shortly before use and lasted 60 min. The number of beam crossings underwent a repeated-measure ANOVA (Statistica Software), with lesion/sham as the between-group factor (two levels) and testing sequence (12 levels), the within-group factor.
Timed intravenous PTZ infusion test
PTZ (10 mg/kg ; Sigma, USA) was infused to NVHL and sham-operated rats aged about PD 80 by means of a butterfly cannula (needle size 27 G, Medex Medical, France) inserted into the tail vein and attached to a 10 ml syringe. The needle was secured to the tail with adhesive tape. The syringe was held in the adjustable motor-driven infusion pump (Harvard, USA). Before the onset of PTZ infusion the animals were placed into Plexiglas boxes where they could move freely. PTZ was infused at a constant rate of 3 ml/h while rats underwent clinical observation and electroencephalographic (EEG) recordings for seizure occurrence. For EEG recordings, rats were anaesthetized by i.p. injection of 37 mg/kg ketamine (Ketalar ; Pfizer, USA) and 5.5 mg/kg xylazine (Rompun, Germany). Four singlecontact electrodes were placed over the frontoparietal cortex, two on each side to allow bilateral EEG recording. Animals were allowed to recover from surgery for 1 wk. The EEG was recorded with a digital computer-based acquisition (Coherence, France). A cortical EEG baseline was recorded for 15 min before the onset of PTZ infusion.
The time latencies and threshold doses in mg/kg to the occurrence of the first spike-and-wave discharge (SWD), the first myoclonia and the first clonic seizure were recorded. PTZ infusion was stopped at the onset of clonic seizures. Analysis between groups for each type of seizure was performed by a Mann-Whitney U test.
Immunohistochemistry
At PD 130, animals were killed by an overdose of pentobarbital (1.8 g/kg Dolethal 1 ; Vetoquinol, France) and perfused transcardially with ice-cold phosphate-buffer (PB 0.1 M ; pH 7.4) followed by icecold fixative (4 % paraformaldehyde, 15 % saturated picric acid in 0.1 M PB ; pH 7.4). Brains were removed, post-fixed with the same fixative overnight at 4 xC and impregnated with 20 % sucrose in 0.1 M PB for cryoprotection. Frontal 40 mm sections were collected in PB and stored at x20 xC in antifreeze solution (0.1 M PB, 30 % ethylene glycol, 30 % glycerol). The immunochemical reactions were performed on five consecutive sections in each animal and at each level.
Immunoperoxidase staining was performed with primary antibodies against PV, CB (rabbit polyclonal antibodies ; Swant, Switzerland), CR (goat polyclonal antibody ; Santa Cruz Biotechnology, USA), GAD67 (mouse monoclonal antibody ; Chemicon International ; UK) and gat-1 (rabbit polyclonal antibody ; Abcam, France). The dilution of the antibodies were as follows : PV 1/10 000, CB 1/20 000, CR 1/500, GAD67 1/1000, gat-1 1/2000. Free-floating sections were incubated overnight with primary antibodies [0.1 M phosphate-buffered saline (PBS), 0.2 % Triton X-100, 2 % goat or rabbit serum] and then washed three times with 0.1 M PBS and Triton 0.2 %. Before incubation for 2 h with the biotinylated secondary antibody (1/200 ; Santa Cruz Biotechnology), sections were pre-treated with 0.3 % hydrogen peroxide in PBS for 15 min. After washing with PBS-Triton, sections were incubated in diluted 1/100 ABC solution (Vectastain Elite kit ; Vector Laboratories, USA) in 0.1 M PBS and 0.2 % Triton for 30 min, washed and incubated with 0.2 mg/ml diaminobenzidine tetrahydrochloride intensified with 2 % nickel (Sigma) as chromogen. The colour reaction was stopped after 5-10 min with ice-cold PB, sections were washed, mounted on gelatin-coated slides, dehydrated and coverslipped.
Readings were performed at different levels according to the stereotaxic coordinates of the rat brain atlas of Paxinos & Watson (1986) : (1) 3.70 mm from bregma for the prefrontal cortex ; (2) 0.70 mm from bregma for the septum, the caudate and nucleus accumbens ; (3) x1.40 mm from bregma for the anterior and reticular thalamic nuclei ; (4) x2.80 mm from bregma for the dorsal hippocampus, lateral and median thalamus, amygdala and piriform cortex and (5) x5.20 mm from bregma for the entorhinal cortex, ventral tegmental area and substantia nigra. The different levels were the same for all animals. Quantification of immunoreactive cells was evaluated using a 1 cm 2 microscopic grid divided into 10r10 boxes on coronal sections. The grid was placed on a defined area of the region of interest and counting was performed with a microscopic enlargement of r200 or r400. Cell counts were performed twice on each side in each region by a single observer unaware of animal's treatment and averaged. Neurons touching the inferior and right edges of the grid were not counted. A prior study by Xu et al. (2004) compared the unbiased cellcounting technique (stereology) to the one used in the present study and demonstrated that the unbiased estimates of the total neuron number in various brain regions were highly correlated with the biased estimates, confirming that the biased cell-counting technique is a simple and reliable method to estimate the number of neurons. Analysis of statistical differences between groups was performed by a Mann-Whitney U test using Statistica software.
In addition, the surface areas of brain regions in which counting was performed were measured with MCID Elite software. Comparisons between regional surface areas of NVHL and sham-operated rats were performed by a Mann-Whitney U test using Statistica software.
Results
Criteria used to select rats for further analyses
Ten out of the 40 NVHL rats that underwent the complete set of studies developed a bilateral symmetrical lesion restricted to the ventral part of the hippocampus and were used for the rest of the study. Figure 1 shows a schematic representation of the smallest and largest lesions of the rats included. Subjects with unilateral or extra-hippocampal lesions were discarded. In the 10 NVHL rats, the mean lesion size reached 3.10¡0.22 mm 2 whereas the hippocampus of sham-operated rats (n=8) injected with aCSF was morphologically intact. At the infusion site, rats showed neuronal loss and gliosis.
Behaviour
In sham-operated rats subjected to the PPI test, the prepulse induced a mean inhibition of 75.2¡4.3 % of the startle reflex. In NVHL rats, this inhibition of the startle reflex was significantly reduced to 55.8¡4.5 % (Mann-Whitney Z=2.43, p=0.014 ; Fig. 2 a) . The mean amplitude of the startle response did not differ whatever group was studied (490.6¡68.8 g and 415¡67 g for sham-operated and NVHL rats, respectively).
In sham-operated rats receiving a dose of 0.35 mg/ kg apomorphine, the cumulated number of beam crossings over 5-min periods ranged from 68 to 140 for the 60-min period. In NVHL rats, the number of beam crossings, compared to sham-operated rats, increased as early as 10 min after injection. This number reached a maximum between 15 and 30 min after injection (49-57 % increase in the number of beam crossings compared to sham-operated rats) but never reached values significantly different from sham-operated rats [ANOVA, lesion: F(1, 14)=2.62, p=0.13; time: F(11, 154) =2.46, p=0.007 ; interaction : F(11, 154)=0.91, p=0.53 ; Fig. 2 b] . At the higher dose (0.7 mg/kg), the number of beam crossings was unchanged in sham-operated rats compared to the lower dose (number of beam crossings ranging from 88 to 152). In NVHL rats, we observed a significant effect of lesion [F(1, 13)=8.46, p=0.012], of time [F(11, 143)=7.4, p<0 .0001] and of interaction [F(11, 143)=4.07, p<0.0001] . Indeed, the number of beam crossings was significantly increased by 230 % at 10 min after injection, remained significantly higher (198-262 %) up to 30 min post-injection and returned to values similar to sham-operated rats 45 min after injection (Fig. 2 c) . As described by Grecksch et al. (1999) , the dose of apomorphine used did not cause stereotypic response (e.g. licking or biting) which could have interfered with locomotion.
PTZ infusion test
Whatever group was studied (sham or NVHL), the temporal succession of events induced by PTZ perfusion was the same, but not their sensitivity to PTZ. They were characterized at a behavioural and EEG level simultaneously. We observed successively : (1) isolated spikes with no clinical motor manifestation ; (2) SWDs matching with brief episodes of stop and stare behaviour with vibrissae and facial twitching considered as a clinical absence ( Fig. 3 a) ; (3) brief bursts of spikes or polyspikes associated to myoclonias with slight elevation of the forelimbs (Fig. 3b) ; (4) trains of high-voltage spikes and polyspikes associated with clonic seizures of the limbs (Fig. 3 c ; at this point PTZ infusion was stopped) followed occasionally by (5) a tonic axial seizure characterized on the EEG by large isolated spikes on a low-amplitude background (not shown). The cumulative dose of PTZ was measured for the occurrence of the first SWD, the first myoclonia and the onset of clonic seizures. These features are commonly used to assess brain excitability (Raffo et al. 2008) . The EEG patterns induced by PTZ were not influenced by the neonatal lesion of ventral hippocampus. Namely, the amplitude and frequency of baseline EEG before and between seizures were similar in both groups. Similarly, the duration, amplitude, and frequency of individual spikes or SWDs were identical in the two groups. The only differences between groups concerned seizure thresholds, i.e. brain excitability. In sham-operated rats, seizure thresholds were : 15.5¡0.9 mg/kg for the first SWD ; 27.0¡ 0.9 mg/kg for the first myoclonia and 32.3¡1.7 mg/ kg for the onset of the clonic seizure. In NVHL rats, the first SWD occurred with a significantly lower dose of PTZ (7.86¡1.1 mg/kg, p=0.0012) whereas clonic seizure appeared with a significantly higher dose (39.3¡2.6 mg/kg, p=0.03) (Fig. 4) . No significant difference could be observed for the threshold to the first myoclonia.
Lesion-induced changes of the GABAergic system
Rats used in this part of the study were those used for the PTZ infusion test, i.e. 10 NVHL and eight shamoperated rats in the first group that also underwent behavioural testing. To control the possible consequence of prior PTZ exposure on the GABAergic system we added one reference group of eight sham and six NVHL rats (5/12 rats that had a typical bilateral lesion). These rats were not exposed to PTZ. In the latter groups, immunohistochemical readings were performed on a limited number of regions : prefrontal cortex, hippocampal and amygdalar subregions. The exposure to PTZ and apomorphine did not significantly influence the expression of the markers studied (data not shown).
GAD67 and gat-1 transporter
To explore the effects of neonatal lesion of the ventral hippocampus on the GABAergic system, we quantified, by cell counting, the neurons expressing GAD67, an enzyme for GABA synthesis. Densitometry was used to quantify gat-1, a GABA transporter mainly expressed in axon terminals (Borden, 1996) . Quantification of the number of interneurons was performed in brain regions often considered to be involved in schizophrenia (Kasai et al. 2002) . They included cortices (prefrontal, motor, sensory, cingular, piriform, entorhinal and parietal), limbic areas (hippocampus, amygdala), thalamus, septum, basal ganglia (caudate nucleus, substantia nigra pars reticulata, ventral tegmental area) and nucleus accumbens. Densitometric analysis of gat-1 staining revealed no statistically significant differences between sham-operated and NVHL rats whatever brain region was studied (data not shown). NVHL rats showed a reduced number of GAD67-positive neurons in the prefrontal cortex (31.5 % decrease ; Figs 5, 6), the superficial layer of the parietal cortex (25 % decrease) and piriform cortex (17 % and 24.4 % in the superficial and deep layers, respectively). A significant decrease in GAD67 immunoreactive neurons was also observed in limbic areas. In the hippocampus, GAD67 was reduced by 23.1 % in the CA1 region (Figs 5, 7) and 40.4 % in the CA3 region while in the amygdala, the decrease reached 25.1 % and 29.1 % in the median and basolateral nucleus, respectively. 
GABAergic interneurons
We also quantified the major subpopulations of interneurons based on their differential expression of calcium-binding proteins, PV, CB, and CR on the same regions as above. This quantification revealed differential vulnerability of these cells restricted to the hippocampus, prefrontal and entorhinal cortices. Indeed, we observed, in NVHL rats compared to shamoperated rats, a significant decrease of CR-(27.6 % loss), PV-(22.5 % loss) and CB-(28.9 % loss) positive cells in the CA1 pyramidal cell layer (Figs 7, 8) , whereas in the CA3 pyramidal cell layer, only CRpositive neurons were significantly reduced (29.7 % loss). In the cortices, the number of PV-positive cells was reduced in the prefrontal cortex (30.7 % loss ; Figs 6, 8) and the number of CB-positive neurons was decreased in the entorhinal cortex (50 % loss). No significant differences between sham-operated and NVHL rats were observed in thalamus, amygdala, septum, basal ganglia, nucleus accumbens and other cortical areas (Table 1) . Concurrently with cell counting, we measured the surface area of brain regions and observed no significant differences between sham and NVHL rats.
Discussion
In the present study we investigated the GABAergic system of NHVL adult rats and looked at the potential relation with cerebral excitability and behaviour. We found (1) responsible for GABA synthesis, GAD67, (2) a specific decrease of different populations of interneurons restricted to the hippocampus, entorhinal and prefrontal cortices ; but (3) no alteration of gat-1-positive fibres. These usual behavioural properties of the model, i.e. hyperlocomotion under apomorphine treatment and a deficit in sensorimotor gating were assessed. Moreover, NVHL rats showed changes in cortical excitability reflected by higher susceptibility than shamoperated rats to SWDs and decreased susceptibility to clonic seizures, induced by increasing the doses of the GABA A receptor antagonist, PTZ.
Relevance of the animal model
Conversely to other experimental studies performed on the GABAergic system in schizophrenia, the present study used a model of the pathology rather than a model of acute psychosis, e.g. those using NMDA antagonism. Indeed, the neonatal lesion of the ventral hippocampus induces the progressive appearance of behavioural modifications that begin after puberty and last for the whole life of the animal (Lipska, 2004) . This model has been validated by different groups and this study allowed further validation under our experimental conditions. Indeed, NVHL rats showed a reduced %PPI reflecting that the neonatal lesion of the ventral part of the hippocampus induced a significant deficit in the inhibition of the startle reflex, as observed previously (Le Pen & Moreau, 2002 ; Le Pen et al. 2003 ; Risterucci et al. 2005) . The deficit in PPI is commonly interpreted as a sensorimotor gating deficit (Braff et al. 1992 ) and is also observed in patients with schizophrenia (Parwani et al. 2000 ; Perry et al. 2002 ; Weike et al. 2000) and schizotypic personality disorder (Cadenhead et al. 2000) . Moreover, NVHL rats presented hyperlocomotion under apomorphine, as reported previously (Lipska et al. 1993 ; Schroeder et al. 1999) . Their hypereactivity to apomorphine, a dopaminergic agonist is a behavioural index consistent with increased mesolimbic dopamine responsiveness, one of the major pathological mechanisms believed to be involved in schizophrenia (Laruelle & Abi-Dargham, 1999) . These data together with the histological examination of the lesions confirm the characteristic features induced by the postnatal lesion of the ventral hippocampus, already published by other groups (Lipska, 2004) . This validation represents a prerequisite for the exploration of GABAergic transmission and excitability of neuronal networks.
Inhibitory interneurons and cortical excitability
Cortical excitability depends on the balance between inhibitory and excitatory inputs which terminate on pyramidal cells. The activity of pyramidal cells is modulated by GABAergic interneurons (Daskalakis et al. 2007 ). In the case of reduced GABAergic tone, possibly resulting in NVHL rats due to a reduction in the number of GABAergic interneurons and reduced levels of GABA secondary to reduced expression of GAD67, as found in the present study, increased excitability could occur. At the level of cortical and hippocampal pyramidal cells the missing GABAergic neurons should result in higher susceptibility to PTZ-induced electrographic events. However, NVHL rats developed clonic seizures at slightly higher doses of PTZ compared to sham-operated rats, which might mean decreased excitability. PTZ-induced clonic seizures involve the cerebral cortex, most hippocampal subfields, the midbrain and brainstem regions (Andre et al. 1998 ). Since the model used here is based on a large bilateral lesion of the ventral hippocampus at a critical stage of brain development, the limbic circuits interconnected with the hippocampus during maturation differ in NVHL rats compared to shamoperated rats (Goto & O'Donnell, 2003) . This could result in a reduced propagation of the seizure and hence an increase of the threshold to generalized clonic seizures. More surprisingly, NVHL rats developed SWDs at a dose of PTZ 2-fold lower than in sham-operated rats meaning increased susceptibility to absence-like seizures. The thalamo-cortical circuit which is involved in the generation of this type of seizure is not directly related to the lesioned brain region. However, 14 d after the neonatal hippocampal lesion, NVHL rats showed a widespread increase in basal brain metabolism in almost all brain regions suggesting an extended reorganization process even beyond direct connections of the lesioned hippocampus (J. François and A. Nehlig, unpublished data) . Moreover, cerebral glucose utilization was higher in the limbic system in humans with typical childhood absence epilepsy (Engel et al. 1985 ; Ochs et al. 1987) and in a genetic rat model of absence epilepsy (Nehlig et al. 1991) supporting some involvement of the limbic system to absence-like seizures. In the present situation, the rewiring of the limbic circuits after the lesion in NVHL rats resulted in pathophysiological alterations of several other circuits (Flores et al. 2005 ; Goto & O'Donnell, 2002 ; Grace, 2000) . Thus, the lesion may modify the interconnectivity between limbic and thalamo-cortical circuits and, subsequently favour the expression of absence-like seizures in these rats. These changes could result from reduced inhibition of GABAergic interneurons. Distinct subpopulations of GABA neurons appear to have specialized functions in regulating hippocampal and cortical pyramidal neuron activity. Parvabumin is expressed in chandelier and basket cells. Chandelier cells project exclusively on the axons' initial segments while the axons of basket interneurons mainly target the cell bodies and proximal dendrites of pyramidal neurons. These two cell types have a fast-spiking, non-adapting firing pattern. The proximity of their projections to the site of action potential generation in pyramidal neurons indicates that these GABA interneurons might be specialized in regulating the output of pyramidal neurons . CB and CR are mainly expressed in double bouquet cells, which are not fast-spiking and provide axon terminals that synapse on the distal dendrites of pyramidal cells, hence apparently selectively modulating interactions between inputs arriving at different cortical layers (Zaitsev et al. 2005) .
How the changes in GABA transmission recorded in the present study could mediate the changes in excitability and schizophrenia-like symptoms in NVHL rats remains unclear. Interneurons structure the activity of pyramidal cells and accurately time and synchronize pyramidal cell discharge. The different types of interneurons may fire preferentially at distinct timepoints during oscillation (Somogyi & Klausberger, 2005) . Interestingly, alterations in oscillations in the gamma band were reported in schizophrenia patients during cognitive tasks (Cho et al. 2006 ; Uhlhaas et al. 2006) . However, there is a need for such a study in NVHL rats.
In a broader fashion, the changes in GABA transmission probably interact with other neurotransmission systems. Indeed, dopamine and glutamate receptors are located on GABAergic interneurons. Regarding the link between GABA and dopamine, it has recently been shown that the modulation by dopamine of interneurons is possibly altered in NVHL rats after adolescence (Tseng et al. 2008) . In the same line, pyramidal cells from the prefrontal cortex show abnormal reactivity to NMDA agonists and antagonists only after puberty (Al-Amin et al. 2001 ; Tseng et al. 2007) . These data suggest a disruption of the interactions between GABA, dopamine and glutamate systems in NVHL rats, as also suggested in humans by Carlsson et al. (2001) Widespread decrease of GABA synthesis : relevance to schizophrenia
An extended decrease of GAD67-positive neurons was observed, particularly in cortical and limbic areas. The number of GAD67-containing neurons decreased not only in the prefrontal cortex and hippocampus of NVHL rats but also in parietal and temporal cortices, and in the amygdala. These results are consistent with human studies on schizophrenia patients where a decrease in GAD67 expression was also quite widespread and found in prefrontal cortex (Guidotti et al. 2000) , hippocampus (Heckers & Konradi, 2002) and temporal cortex (Impagnatiello et al. 1998) . Similar decreases were found in brains of patients with bipolar disorders but notably not in patients with unipolar depression suggesting that GAD67 decrease is a specific feature of psychotic disorders (Guidotti et al. 2000) . However, we also observed a disparity between the widespread decrease in GAD67 expression and a lack of change in calcium-binding proteins, namely in amygdala, parietal and temporal cortices. This disparity could originate either in a decrease of GAD67 without loss of interneurons, or reflect the loss of other interneuron populations that were not studied here, e.g. neuropeptide Y and somatostatin interneurons.
In the present study we worked with a rat model in which we provoked a large lesion of the ventral hippocampus. In schizophrenia patients, the cortical grey matter appeared thinner which was interpreted as the consequence of reduced neuropil (Jarskog, 2006) . However, this did not seem to correspond to a largescale neuronal loss. The lesion itself does not represent the key factor of the structural changes of the NVHL model. The excitotoxic lesion, performed during the neonatal period, disrupted the normal development and induced disconnexions in cortical and subcortical circuits. This mechanism is in agreement with the neurodevelopmental hypothesis of schizophrenia where similar diffuse alterations occur, but for reasons that are unrelated to such a dramatic hippocampal lesion. In this regard, our results suggest that a brain insult during development could induce an abnormal reorganization of the GABAergic system leading to a loss of cortical inhibition that might underlie the behavioural and cognitive abnormalities observed in this model.
Perturbation of specific GABAergic subsystems : relevance to schizophrenia
In NVHL rats, we found a specific decrease of the density of interneurons positive for PV in two brain regions, the prefrontal cortex and the CA1 pyramidal cell layer of the hippocampus. This result is consistent with data from schizophrenia patients that reported a decrease in PV immunoreactive neurons (Beasley & Reynolds, 1997 ; Reynolds & Beasley, 2001 ) and PV mRNAs (Hashimoto et al. 2003) in layers III and IV of the prefrontal cortex and in all subfields of the hippocampus post-mortem (Zhang et al. 2002) . Such a decrease was also found in other animal models of acute psychosis such as those induced by NMDA receptor antagonism in rats (Abekawa et al. 2007 ; Braun et al. 2007) or monkeys (Morrow et al. 2007) . Taken together, these data suggest here the relevance of the overreported region-specific loss of PV interneurons for schizophrenia. They reinforce the validity of the model used. In addition, the PV cell population appears to be the only one among the GABAergic interneuron population to be affected in the prefrontal cortex, a brain region whose perturbation is assumed to alter the executive functions in patients.
We found also a decrease in CB-positive neurons in the hippocampus and entorhinal cortex which corresponds to another frequently reported alteration of the hippocampus of schizophrenia patients (Iritani et al. 1999) and of other animal models (Harte et al. 2007) .
However, in addition we found a reduction of the density of CR-containing neurons in the hippocampus. The NVHL rats represent to our knowledge the only model for schizophrenia in which the number of CR-immunopositive neurons were shown to be reduced. No change in the CR population of neurons was reported in schizophrenia patients (Eyles et al. 2002) or in other animal models, such as those using NMDA antagonists (Reynolds et al. 2004 ; Wang et al. 2008) . This suggests that the loss of CR interneurons could be a specific aspect of the lesion model that remains unrelated to schizophrenia. For example, a loss of CR interneurons was also found in a model of temporal lobe epilepsy associated with lesions of the hippocampal formation (Andre et al. 2001) .
Conclusions
In the present study we showed that a neonatal lesion of the ventral hippocampus induced selective alterations in the GABAergic system leading to functional consequences on brain excitability. These results gave evidence for the implication of perturbations of the GABAergic system in the pathophysiology of schizophrenia that could be due to brain insults during early development.
